The 1000 Genomes Project is an international collaboration to produce an extensive public catalog of human genetic variation, including SNPs and structural variants, and their haplotype contexts. This resource will support genome-wide association studies and other medical research studies. The genomes of about 2500 unidentified people from about 25 populations around the world will be sequenced using next-generation sequencing technologies. The results of the study will be freely and publicly accessible to researchers worldwide. Amongst the individuals being sequenced there are also DNA samples from 100 Finnish volunteers

Read more from their official website at www.1000genomes.org/home.

The aims of Botnia cohort has been collected from the western coast of Finland in the Gulf of Bothnia for four different studies studying type 2 diabetes. The Botnia Study, started in 1990,  is one of the largest diabetes family studies in the world. The initial family based Botnia study comprised of 11000 individuals as well as a prospective 10-year follow-up of 2800 individuals. The Botnia study also includes a population based study of 5200 individuals aged 18-75 with an ongoing 6-year follow-up study. A project aiming to cover all diabetic patients in the region has also been launched and includes at the moment more than 4000 individuals. The study includes individuals from about 4000 families (about 1000 independent trios) and extensive phenotype information is available for all study participants. The current SISu release includes 168 samples from this study.

Read more from their official website at http://www.botnia-study.org/en/home/.

EUFAM (European Study of Familial Dyslipidemias) study is a project aiming to reveal the molecular and genetic basis of familial combined hyperlipidemia (FCHL) and of familial low high-density cholesterol (HDL-C). The study cohort comprises of over 1500 family members from 140 Finnish families with premature coronary heart disease and with either FCHL or familial low HDL-C. The EUFAM study aims to characterize detailed geno- and phenotypes of these familial dyslipidemias utilizing current high-throughput technology of both genetics and molecular biology. 36 samples of this study are included in the SISu dataset. 

The Finland-United States Investigation of NIDDM Genetics (FUSION) dataset is collected for localizing and identifying genetic variants that predispose to type 2 diabetes mellitus (T2D) or are responsible for variability in diabetes-related quantitative traits. The FUSION study sample includes approximately 800 families ascertained for sibling pairs affected with type 2 diabetes, including also parents, unaffected siblings, spouses and children in some cases; ~200 unrelated individuals with normal glucose tolerance at ages 65 and 70 years, with their spouses and children in some cases; and ~8400 mostly unrelated individuals including ~1700 type 2 diabetics selected from the D2D 2004, Finrisk 1987, Finrisk 2002, Health 2000, Action LADA, and Savitaipale Diabetes studies. 831 of these samples (not included in Finrisk 1987, Finrisk 2002, or Health 2000) are currently part of SISu. 

Read more from their official website at https://fusion.sph.umich.edu/. 

The cross-sectional METSIM (METabolic Syndrome In Men) Study includes 10,197 men, aged from 45 to 73 years, randomly selected from the population register of the Kuopio town, Eastern Finland, and viagra pour femme en france examined in 2005-2010. The aim of the study was to investigate genetic and non-genetic factors associated with the risk of type 2 diabetes (T2D), cardiovascular disease (CVD), and insulin resistance –related traits in a cross-sectional and longitudinal setting. The SISu dataset includes 823 samples from this study. 
 

The Migraine Family Study sample consists of migraine patients visiting headache clinics, from which extensive questionnaire data for headache and co-morbid disorders has been collected. The study combines the best possible phenotyping in large samples with cutting edge genetic techniques, including high throughput genotyping and novel tools of statistical genetics. The aim is to identify gene variants and assess their impact in ascertained family and case control samples and subsequently study their population relevance in large international population samples. 348 samples of this study are included in the SISu dataset.

Read more from their official website at https://www.fimm.fi/en/press-release/1466436294.

The Finnish Twin Cohort was first established in 1974 to investigate genetic and environmental risk factors for chronic disorders. Twins and their families have been ascertained in three stages from the Central Population Register in 1974 (older like-sexed pairs), 1987 (multiple births 1968-1987) and 1995 (opposite-sex pairs 1938-1957). There are a total of 12,966 MZ and DZ twin pairs (25,932 individuals) with both members currently alive and excluding individuals who refused to participate in studies. Over 15000 DNA samples have been collected in this study, and serum and other biological samples are available from several sub-studies as well. SISu includes 258 samples from this cohort. 

Read more from their official website at https://wiki.helsinki.fi/display/twineng/Twinstudy.